In a joint statement issued early Tuesday, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) say experts are reviewing data showing six cases of a “rare and severe” type of blood clot.
As of Monday, more than 6.8 million doses of the J&J vaccine have been administered, according to the CDC.However, a production bottleneck has slowed recent flow of the vaccine to Texas, the Texas Tribune reports. The state expected to get about 500,000 doses of the vaccine this week but was allotted just 130,000 through state and federal programs.
Pfizer and Moderna vaccines are not included in the CDC’s and FDA’s recommended pause and continue to be viewed as safe to distribute, according to available information.The CDC and FDA urges caution for anyone who received the J&J vaccine recently.
Johnson & Johnson responded to concern, saying it's working with regulators to assess the data, according to ABC News.
"We are aware that thromboembolic events including those with thrombocytopenia have been reported with COVID-19 vaccines," says the corporation. "At present, no clear causal relationship has been established between these rare events and the Janssen COVID-19 vaccine. We continue to work closely with experts and regulators to assess the data and support the open communication of this information to healthcare professionals and the public."
The CDC asks health care providers to report adverse events to the Vaccine Adverse Event Reporting System at vaers.hhs.gov/reportevent.html.
Sanford Nowlin contributed to this report.
This story first appeared in CityBeat Cincinnati, an affiliated publication.
Stay on top of San Antonio news and views. Sign up for our Weekly Headlines Newsletter.
Support Local Journalism.
Join the San Antonio Current Press Club
Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.
Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.
Join the San Antonio Press Club for as little as $5 a month.